Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry

Get report
Skip to content

Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry

Get report
  • There are no suggestions because the search field is empty.
Request a Demo
Request a Demo

Core Capabilities

Featured

Radar metrics
BLOG The market has changed: Frost & Sullivan's 2026 Radar shows who's leading it RapidAI Chief Business Officer David Stoffel, MD, MBA, breaks down what this recognition signals — and what it means for health systems planning their AI strategy for the years ahead LEARN MORE
Platform overview
Request a Demo

RADIOLOGY SUPPORT

Neurovascular

Cardiac + vascular

LIFE SCIENCES

Featured

Cognitive Burden index RapidAI 2025
BLOG Radiology’s real challenge Read about the reality of cognitive burden LEARN MORE
Request a Demo

BUILT TO SUPPORT THE FULL SYSTEM

FEATURED

Resource_1600x900_C-Suite-Exec Insights_white paper
WHITE PAPER Empowering healthcare leaders with a deep clinical AI enterprise platform Learn how AI can address real-world challenges for administrators LEARN MORE
Overview
Request a Demo

Core Capabilities

Featured

Radiology Rewired podcast
PODCAST Season 1 available now Exploring how AI is transforming Radiology—one conversation at a time with clinicians and innovators LEARN MORE
Overview
Request a Demo

TRAINING & LEARNING

HELP & ASSISTANCE

Overview
Request a Demo

LEARN MORE ABOUT RAPIDAI

WORK WITH US

FEATURED

video thumbnail for dr Gregory Albers
VIDEO The story behind RapidAI Hear our founder, Greg Albers, MD, tell the history of how the company came to be Watch now
Company overview
Request a Demo
Press Release

RapidAI Celebrates International Adoption of AI-Powered Stroke Care

The company today announced unprecedented growth in the adoption and use of the Rapid platform around the world with nearly 300% growth.

Share to

The company today announced unprecedented growth in the adoption and use of the Rapid platform around the world with nearly 300% growth.

San Mateo, Calif. — November 12, 2020 — RapidAI, the leader in advanced imaging for stroke, today announced unprecedented growth in the adoption and use of the Rapid platform around the world. Now approved in over 60 countries and utilized in over 1,600 hospitals, the company has experienced a year-over-year increase in just International Rapid scans (outside the U.S.) of nearly 300%, comparing Q3 2019 to Q3 2020. RapidAI makes the most-widely used advanced cerebrovascular imaging products for patient care, research, and clinical trials across the globe. RapidAI clinical products help save lives, RapidAI workflow and messaging technologies help stroke teams save time, and RapidAI analytics and business intelligence products help stroke networks reduce costs and improve patient outcomes. “The number of people who suffer a stroke worldwide each year is staggering, over fifteen million,” offered Marc Hofmans RapidAI Senior Vice President of Sales, EMEA. “While it is no small task, our mission is to bring AI-powered stroke imaging to every corner of the globe. With Rapid now in more than 60 countries, we are well on our way.” After celebrating the one-millionth Rapid scan in July of this year, RapidAI now reports that it is on an accelerating run-rate to deliver one-million scans in 2020, alone. With the goal of saving lives and improving the outcomes for more and more patients, RapidAI is also on track to reach the major milestone of a million total patients scanned by the end of this year. RapidAI International Growth Rapid in use in over 1,600 hospitals worldwide Rapid now in more than 60 countries 298% growth in Rapid scans, outside the U.S., (Q3 2019 to Q3 2020) 275% growth in patients scanned with Rapid, outside the U.S., (Q3 2019 to Q3 2020) Run-rate to deliver one-million Rapid scans worldwide in 2020 On track to scan a total of one-million patients worldwide, with Rapid, by the end of 2020 “ I see artificial intelligence as the future in the fast-moving world of diagnostic and therapeutic stroke management,” said Dr. Sanjeev Nayak, Royal Stoke NHS UK. “Using AI will help stroke victims when 'Time Is Brain'. RapidAI has helped stroke patients by providing positive insight to the treating clinicians by accelerating stroke diagnosis. This ensures accurate therapeutic intervention in the shortest possible time after the onset of stroke. ” Rapid is the only clinically validated platform available and considered by many to be the gold standard for advanced cerebrovascular imaging. To learn more visit www.RapidAI.com . About RapidAI RapidAI is the worldwide leader in advanced imaging for stroke. Based on intelligence gained over 1,000,000 scans from more than 1,600 hospitals in over 60 countries, the Rapid® platform uses artificial intelligence to create high quality, advanced images from non-contrast CT, CT angiography, CT perfusion, and MRI diffusion and perfusion scans. The Rapid imaging platform includes Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid LVO, Rapid CTP, and Rapid MRI. RapidAI also offers SurgicalPreview®, a comprehensive aneurysm management platform. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically-proven, data-driven technology. With our validated, trusted products developed by medical experts, clinicians worldwide are improving patient care and outcomes every day. For more information, visit RapidAI.com.

Contact PR

Jessica Stebing

Jessica Stebing

Group Manager, Marketing Communications

stebing@rapidai.com